Erbitux might help lung cancer fight
A cancer drug used to treat colon, head and neck cancer is said to boost survival rates in patients with certain type of lung cancer. Janet Babin reports dramatic Erbitux trial results could make prescriptions explode.
This entry was posted on Friday, May 30th, 2008 at 4:11 pm and is filed under Research, Treatment. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.